Cargando…

Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()

Detalles Bibliográficos
Autores principales: Lasheras, Isabel, Santabárbara, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242950/
https://www.ncbi.nlm.nih.gov/pubmed/32835091
http://dx.doi.org/10.1016/j.medcle.2020.04.002
_version_ 1783537334008938496
author Lasheras, Isabel
Santabárbara, Javier
author_facet Lasheras, Isabel
Santabárbara, Javier
author_sort Lasheras, Isabel
collection PubMed
description
format Online
Article
Text
id pubmed-7242950
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-72429502020-05-22 Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?() Lasheras, Isabel Santabárbara, Javier Med Clin (Engl Ed) Article Elsevier España, S.L.U. 2020-07-10 2020-05-22 /pmc/articles/PMC7242950/ /pubmed/32835091 http://dx.doi.org/10.1016/j.medcle.2020.04.002 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lasheras, Isabel
Santabárbara, Javier
Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()
title Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()
title_full Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()
title_fullStr Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()
title_full_unstemmed Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()
title_short Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()
title_sort use of antimalarial drugs in the treatment of covid-19: a window of opportunity?()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242950/
https://www.ncbi.nlm.nih.gov/pubmed/32835091
http://dx.doi.org/10.1016/j.medcle.2020.04.002
work_keys_str_mv AT lasherasisabel useofantimalarialdrugsinthetreatmentofcovid19awindowofopportunity
AT santabarbarajavier useofantimalarialdrugsinthetreatmentofcovid19awindowofopportunity